Midwest
Ohio
Ohio has a baseline federal posture but pharmacies report heightened caution around peptides after repeated enforcement attention in regenerative medicine.
Legal context
Compounding decisions tend to mirror federal category signals closely, especially for injectable peptides.
What this means
Injectable aesthetics and performance peptides are the first to disappear from local menus.
Compounding partners often require a direct legal review before accepting new peptide requests.
Patients should expect substitutions toward FDA-approved or legacy compounded alternatives.